Posts Tagged ‘Topamax’

topamaxThe AP (10/15) reported, “Mylan Inc. said Thursday it received regulatory approval for its version of Johnson & Johnson’s epilepsy drug Topamax [topiramate], and began shipping” the “15 milligram and 25 milligram topiramate sprinkle capsules.” The patents “on Topamax expired in March,” and the AP notes that “Teva Pharmaceutical Industries Ltd. also markets a generic version of the drug.”

Read Full Post »